-+ 0.00%
-+ 0.00%
-+ 0.00%

SCISPARC ANNOUNCES CLOSING OF THE SALE TO N2OFF OF MAJORITY-OWNED SUBSIDIARY MITOCAREX, ADVANCING DRUG DISCOVERY FOR RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL CELL LUNG CANCER

Reuters·10/23/2025 20:03:00

Please log in to view news